The EPS beat and strong procedure growth are positive, but the guidance midpoint (~14.5% procedure growth) signals deceleration from Q2's 16%, watch for any commentary on procedure mix or hospital capital spending on the call.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 17 $345.42entry
- T+1 · 4mo ago +2.24%α +2.41% · $353.17
- T+5 · 4mo ago −3.88%α −3.19% · $332.02
- T+20 · 3mo ago +14.18%α +9.74% · $394.41
- T+60 · 5w ago +23.80%α +19.12% · $427.64
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Intuitive Surgical reported Q2 2026 non-GAAP EPS of $2.80, beating consensus of $2.59 by 8.2%, on revenue of $2.89B (in line with $2.89B consensus, +19% YoY). Worldwide procedure growth of ~16% and strong da Vinci 5 placements (246 systems) drove results, but the stock's historical pattern shows poor follow-through on bullish calls, and the guidance midpoint implies decelerating procedure growth to ~14.5% for full-year 2026, tempering the beat's impact.
Key Financial Metrics
Key Facts
- Non-GAAP EPS of $2.80 beat consensus of $2.59 by 8.2%
- Revenue of $2.89B grew 19% YoY, in line with consensus
- Worldwide procedures grew ~16% YoY (da Vinci +15%, Ion +36%)
- Placed 468 da Vinci systems, including 246 da Vinci 5 systems
- Full-year 2026 procedure growth guidance midpoint of ~14.5% implies deceleration from Q2's 16%
- Non-GAAP gross margin guidance of 68.0%-69.0% includes ~1% tariff headwind
- Repurchased 0.9M shares for $0.38B in Q2
Financial Impact
Non-GAAP EPS beat consensus by $0.21 (8.2%); revenue in line at $2.89B
Risk Factors
- Tariff headwinds could pressure gross margins beyond guided 68.0%-69.0% range
- Procedure growth deceleration to ~14.5% in H2 2026 vs 16% in Q2
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3328793 |
Track record
39 reports on ISRG
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +16.76% at T+60 after the Aug 12, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $439.89 Now $437.75 −0.49% settles Dec 11
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $449.53 Now $437.75 −2.62% settles Dec 10
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $468.52 Now $437.75 −6.57% settles Dec 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $468.52 Now $437.75 −6.57% settles Dec 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $440.75 Now $437.75 −0.68% settles Dec 2
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $436.87 Now $437.75 +0.20% settles Dec 1
- Oct 28, 202619d ago Insider Cluster Neutral 2/10 Entry $448.76 Now $437.75 −2.45% settles Nov 27
- Oct 28, 202619d ago Insider Cluster Neutral 2/10 Entry $448.76 Now $437.75 −2.45% settles Nov 27
- Oct 26, 202621d ago Insider Cluster Neutral 2/10 Entry $451.63 Now $437.75 −3.07% settles Nov 23
- Oct 23, 202624d ago 144 Neutral 3/10 Entry $451.63 Now $437.75 −3.07% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers